Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitis

A limited number of therapeutic strategies are currently available for patients with inflammatory bowel disease (IBD). In particular, the maintenance therapy after remission in Crohn's disease (CD) is not satisfactory and new approaches are needed. Interleukin-10 gene-deficient (IL-10(–/–)) mic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Matsuda, C, Ito, T, Song, J, Mizushima, T, Tamagawa, H, Kai, Y, Hamanaka, Y, Inoue, M, Nishida, T, Matsuda, H, Sawa, Y
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Science Inc 2007
Soggetti:
Animal Studies
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1868878/
https://ncbi.nlm.nih.gov/pubmed/17437423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2007.03345.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi